Fund Holdings — Krensavage Asset Management, LLC

Total Portfolio Value:
$188.9K
Total Bought:
$22.7K
Total Sold:
$19.9K
Net Transaction:
+$2.8K
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
United Therapeutics Corporation(UTHR)98,228101,146+2,918$30.3K$29.1K15.38%-$1.2K
Cardinal Health, Inc.(CAH)188,745133,745-55,000$26.0K$22.5K11.89%-$3.5K
Exelixis, Inc.(EXEL)878,533493,526-385,007$32.4K$21.8K11.51%-$10.7K
Jazz Pharmaceuticals plc(JAZZ)100,703164,816+64,113$12.5K$17.5K9.26%+$5.0K
Enanta Pharmaceuticals, Inc.(ENTA)2,116,5862,114,444-2,142$11.7K$16.0K8.46%+$4.3K
Supernus Pharmaceuticals, Inc.(SUPN)431,986472,376+40,390$14.1K$14.9K7.88%+$741
Indivior Plc965,368974,474+9,106$9.2K$14.4K7.60%+$5.2K
GSK plc(GSK)272,000271,729-271$10.5K$10.4K5.52%-$103
Avadel Pharmaceuticals950,000958,877+8,877$7.4K$8.5K4.49%+$1.0K
BioNTech SE(BNTX)87,56373,382-14,181$8.0K$7.8K4.14%-$160
Sanofi(SNY)149,096148,946-150$8.3K$7.2K3.81%-$1.1K
Johnson & Johnson(JNJ)040,000+40,000$0$6.1K3.23%+$6.1K
Alkermes plc(ALKS)207,822207,8220$6.9K$5.9K3.15%-$916
Vanda Pharmaceuticals Inc.(VNDA)754,3811,024,883+270,502$3.5K$4.8K2.56%+$1.4K
Regeneron Pharmaceuticals, Inc.(REGN)04,000+4,000$0$2.1K1.11%+$2.1K
Mural Oncology Plc70,2630-70,263$89$0—-$89
Page 1 of 1
Krensavage Asset Management, LLC — 13F Holdings — Q2 2025 | TickerTrail